Maintaining functioning in bipolar disorder: Treat early and prevent relapses

Our correspondent’s highlights from the symposium are meant as a fair representation of the scientific content presented. The views and opinions expressed on this page do not necessarily reflect those of Otsuka and Lundbeck.

References
  1. López-Jaramillo et al. Bipolar Disord 2010;12:557–567.
  2. Kraepelin. Manic Depressive Insanity and Paranoia. Salem, NH: Ayer Co., 1921, (reprinted 1976)
  3. Zis et al. Psychopharmacol Bull 1980;16:47–49.
  4. Angst et al. Schizophr Bull 1980;6:579–585.
  5. Roy-Byrne et al. Acta Psychiatr Scand Suppl 1985;317:1–34;
  6. Kessing et al. J Affect Disord 1998;49:101–108
  7. Arumugham et al. J Affect Disord 2017;222:23–27.
  8. Hibar et al. Mol Psychiatry 2016;21:1710–1716.
  9. Joyce et al. Int J Bipolar Disord 2016;4:19.
  10. Zalpuri & Singh. Curr Treat Options Psychiatry 2017;4(4):341–356
  11. Gignac et al. J Affect Disord 2015;175:411–417.
  12. Kozicky et al. Bipolar Disord 2016;18:511–519.
  13. Kozicky et al. J Clin Psychiatry 2014;75:e587–e593.
  14. Aiken et al. J Affect Disord 2015;177:59–64.
  15. Sachs et al. J Clin Psychi. 2011; 72:704-15.
  16. Tohen et al. Am J Psychiatry 2000;157:220-228.
  17. Rosa et al. Psychother Psychosom 2008;77:390-392.
  18. Grande et al. Lancet 2016;387:1561-1572.
  19. Rosa et al. Clin Pract Epidemiol Ment Health 2007;3:5.
  20. Calabrese et al. J Affect Disord 2018;227:649-656.
  21. Sanchez-Moreno et al. Acta Psychiatr Scand 2018;138:145-154.
Country selection
We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil
You are leaving Progress in Mind
Hello
Please confirm your email
We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.
The information on this site is exclusively intented for health care professionals.
All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.
Congress
Register for access to Progress in Mind in your country